Quarterly Result29 May 2026, 01:43 pm

ADS Diagnostics: FY26 Audited Results; Dividend of ₹1.20/Share

AI Summary

ADS Diagnostics Ltd's board approved the audited standalone financial results for the quarter and year ended March 31, 2026. The board recommended a dividend of 12%, which is ₹1.20 per share with a face value of ₹10 each, subject to shareholder approval. The Board Meeting commenced at 11:45 a.m. and concluded at 13:32 p.m.

Key Highlights

ADS Diagnostics approved audited standalone financial results for FY26.
The board recommended a dividend of ₹1.20 per share (12%).
Meeting commenced at 11:45 a.m. and concluded at 13:32 p.m.
Revenue from Operations (Net) stood at ₹2,835.75 Lacs for the year ended March 31, 2026.
Equity Share Capital is ₹219.28 Lacs.

View BSE Filing

ADSDIAG

Healthcare Service Provider

ADS DIAGNOSTIC LTD.

Price Impact